Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
6011	Margie, felt obligated to come back one more time as I received further clar	Steve Fancy	-	1/27/1999
6010	Bob Pisani on CNBC just said they are waiting for earnings from Agouron. Guess	margie	-	1/27/1999
6009	One more comparison: Minimum exchange .... Maximum exchange	billkirn	-	1/27/1999
6008	The best case would be for WLA to drop to $64 at the close (about 90 days) and	billkirn	-	1/27/1999
6007	With WLA capital resources and AGPH's product pipeline maybe just maybe WLA	billkirn	-	1/27/1999
6006	Steve, you are the pro! The max I got today was 59 9/16. I have a nice position	Michael L.	-	1/27/1999
6005	Well, good luck to you Margie...thanks for all your contributions. sf	Steve Fancy	-	1/27/1999
6004	I just listened to the conference call and someone asked that question. The up	margie	-	1/27/1999
6003	Last note...not per PW. Deal fixed at 60. Price rise in WLA likely not rel	Steve Fancy	-	1/27/1999
6002	The price is fixed at 60. Suppose something could happen to change the deal	Steve Fancy	-	1/27/1999
6001	There is upside potential to the final price. If WLA shares average above $74 f	margie	-	1/27/1999
6000	Geez! They both are rocketing up! It is impossible, but if... the price will go	Michael L.	-	1/27/1999
5999	CEOs of AGPH and WLA to be interviewed on CNBC today at 11:20 EST.	Jan P	-	1/27/1999
5998	CNBC just mention other anti-viral Biotechs (VRTX, GILD, & VIRS) which now	Henry Niman	-	1/27/1999
5997	You are correct. AGPH will be a subsidiary of WLA. Nothing much should change	sam	-	1/27/1999
5996	Maybe I have this wrong, but Agouron is going to be a subsidiary of Warner-Lamb	margie	-	1/27/1999
5995	Although the deal IMO was not the best "financially" for current AGPH	sam	-	1/27/1999
5994	DJ and WSJ have fairly extensive stories on the AGPH/WLA deal. Details linked t	Henry Niman	-	1/27/1999
5993	Bill, I've followed WLA more in the diabetes area than cardiovascular, and	Henry Niman	-	1/27/1999
5992	I'm not surprised to see the new contributors to this thread bitch. Those	scaram(o)uche	-	1/27/1999
5991	It looks like they ( AGPH management) get to keep their independence, which was	Joe E.	-	1/27/1999
5990	It seems as if AGPH's enemy is TIME. In the back of my head, I'm think	jake burns	-	1/27/1999
5989	It doesn't make sense John. They were gearing up to go it alone with a	Steve Fancy	-	1/27/1999
5988	INTERVIEW-Warner-Lambert aims for Agouron pipeline Reuters, Tuesday, January 2	Steve Fancy	-	1/27/1999
5987	John, you seem to be on the defensive for some reason. I don't dispute	Steve Fancy	-	1/27/1999

Go to reply# or date (mm/dd/yy):